As of Apr 2025 ยท from AVAWATZ Preferred Stock 5 ยท pre-money + amount raised, not a traded price
Total raised
$1,984,026
Across 5 rounds since 2021
Latest share price
$4.00
AVAWATZ Preferred Stock 5 offering price
Financials
FY2019โFY2025 ยท from SEC filings ยท hover any figure for its source
$353K
$81K
2019
$814K
$32K
2020
$758K
$66K
2021
$390K
โ$469K
2022
$0
โ$863K
2023
$281K
โ$562K
2024
$621K
โ$907K
2025
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$352,689
$814,309
$757,681
$389,523
$0
$281,477
$620,659
Cost of goods sold
$191,904
$371,559
$416,855
$223,485
$0
$158,873
$364,023
Gross margin
46%
54%
45%
43%
โ
44%
41%
Net income
$80,562
$31,897
$65,824
-$468,980
-$863,206
-$561,694
-$907,282
Taxes paid
$0
$0
$8,000
-$122,500
$0
$0
$0
Balance sheet
Cash
$199,603
$329,509
$292,359
$390,734
$491,085
$331,374
$336,440
Accounts receivable
$0
$0
$75,000
$0
$0
$0
$223,681
Total assets
$236,212
$424,563
$445,689
$636,975
$884,434
$882,972
$602,892
Short-term debt
$154,150
$285,228
$273,810
$200,388
$192,969
$189,726
$158,475
Long-term debt
$0
$25,376
$4,189
$0
$0
$0
$0
Total liabilities
$154,150
$310,604
$277,999
$200,388
$192,969
$189,726
$158,475
Other
Headcount
โ
13
13
20
21
21
25
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.